Our research demonstrates that TRPC5 is overexpressed in clinical samples of STAD, COAD, and various gastrointestinal cancer cell lines, with its expression negatively correlated with overall patient survival. The gene discussed is TRPC5; the disease is gastric adenocarcinoma.